Concepedia

Juliane Süptitz

JS

Statistics

Publications

3

Citations

170

H-Index

3

Active since

2020

Affiliations

University Hospital Cologne(Current)

LungenClinic Grosshansdorf

German Cancer Research Center

Heidelberg University

Charité - Universitätsmedizin Berlin

Juliane Süptitz is an author at University Hospital Cologne specializing in oncology, medicine, and oncogenic receptor tyrosine kinase mutations.

Publications per year

2020–2023

3

Publications

3

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Melanie Janning, Juliane Süptitz, Corinna Albers et al. · Annals of Oncology · 2022 · 91 citations · Full text

, , +16

Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

Philip Bischoff, Martin Reck, Tobias R. Overbeck et al. · Journal of Thoracic Oncology · 2023 · 48 citations · Full text

, , +17

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

Svenja Wagener‐Ryczek, Carina Heydt, Juliane Süptitz et al. · BMC Cancer · 2020 · 31 citations · Full text

, , +15

1–3 of 3